Korea United Pharm Inc.
KRX:033270.KS
20,800 (KRW) • At close November 4, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Korea United Pharm Inc. |
Symbool | 033270.KS |
Munteenheid | KRW |
Prijs | 20,800 |
Beurswaarde | 305,993,937,600 |
Dividendpercentage | 1.68% |
52-weken bereik | 20,000 - 28,900 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Duk-Young Kang |
Website | https://www.kup.co.kr |
An error occurred while fetching data.
Over Korea United Pharm Inc.
Korea United Pharm Inc. engages in the manufacture and sale of pharmaceutical products in South Korea. It offers products in the areas of respiratory system, musculo-skeletal system, gastro-intestinal tract system, cardiovascular system, anti-cancer, anti-infectives, allergy, immune system, central nervous system, and other diseases, as well OTC drugs. The company also
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (KRW)
Cijfers zijn in miljoenen (KRW)